INC Research Launches Alliance Partnerships Program
Wednesday, February 24, 2010
Raleigh, N.C.-based CRO INC Research launched an alliance partnerships program to create and manage strategic alliances with pharmaceutical and biotech customers. The company said it hopes to create relationships with customers based on joint strategic objectives rather than service agreements.
The services provided by INC through these relationships can include complete management of a compound or therapeutic area, management of a specific function or set of critical processes, sharing in the risk and reward of a compound’s performance, or acting as the sole source development partner for a customer. Tim Dietlin was appointed vice president, alliance development, to oversee the effort.
“Drug developers are starting to realize that the traditional role of a preferred CRO provider is not producing the financial, efficiency and quality benefits they had hoped for,” said INC Research’s executive vice president of strategic development Alistair Macdonald in a statement. “We want to take these relationships to the next level by developing commercial level solutions supported by our excellence in clinical trial execution.”
Quintiles launched a similar effort earlier this year, which recently resulted in a commercialization deal with Belgian pharma company Movetis.